Cannabinoid-induced actomyosin contractility shapes neuronal morphology and growth

  1. Alexandre B Roland
  2. Ana Ricobaraza
  3. Damien Carrel
  4. Benjamin M Jordan
  5. Felix Rico
  6. Anne C Simon
  7. Marie Humbert-Claude
  8. Jeremy Ferrier
  9. Maureen H McFadden
  10. Simon Scheuring
  11. Zsolt Lenkei  Is a corresponding author
  1. ESPCI-ParisTech, France
  2. Université Paris Descartes, Sorbonne Paris Cité, France
  3. Harvard University, United States
  4. Aix-Marseille Université, Parc Scientifique et Technologique de Luminy, France

Abstract

Endocannabinoids are recently recognized regulators of brain development, but molecular effectors downstream of type-1 cannabinoid receptor (CB1R) activation remain incompletely understood. We report atypical coupling of neuronal CB1Rs, after activation by endo- or exocannabinoids such as the marijuana component ∆9-tetrahydrocannabinol, to heterotrimeric G12/G13 proteins that triggers rapid and reversible non-muscle myosin II (NM II) dependent contraction of the actomyosin cytoskeleton, through a Rho-GTPase and Rho-associated kinase (ROCK). This induces rapid neuronal remodeling, such as retraction of neurites and axonal growth cones, elevated neuronal rigidity and reshaping of somatodendritic morphology. Chronic pharmacological inhibition of NM II prevents cannabinoid-induced reduction of dendritic development in vitro and leads, similarly to blockade of endocannabinoid action, to excessive growth of corticofugal axons into the subventricular zone in vivo. Our results suggest that CB1R can rapidly transform the neuronal cytoskeleton through actomyosin contractility, resulting in cellular remodeling events ultimately able to affect brain architecture and wiring.

Article and author information

Author details

  1. Alexandre B Roland

    ESPCI-ParisTech, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Ana Ricobaraza

    ESPCI-ParisTech, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Damien Carrel

    Université Paris Descartes, Sorbonne Paris Cité, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Benjamin M Jordan

    Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Felix Rico

    Aix-Marseille Université, Parc Scientifique et Technologique de Luminy, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Anne C Simon

    ESPCI-ParisTech, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Marie Humbert-Claude

    ESPCI-ParisTech, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Jeremy Ferrier

    ESPCI-ParisTech, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Maureen H McFadden

    ESPCI-ParisTech, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Simon Scheuring

    Aix-Marseille Université, Parc Scientifique et Technologique de Luminy, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  11. Zsolt Lenkei

    ESPCI-ParisTech, Paris, France
    For correspondence
    zsolt.lenkei@espci.fr
    Competing interests
    The authors declare that no competing interests exist.

Ethics

Animal experimentation: Experiments were performed in agreement with the institutional guidelines for the use and care of animals and in compliance with national and international laws and policies (Council directives no. 87-848, 19 October 1987, Ministère de l'Agriculture et de la Forêt, Service Vétérinaire de la Santé et de la Protection Animale). All surgery was performed under Ketamine/Xylazine anesthesia, and every effort was made to minimize suffering.

Copyright

© 2014, Roland et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,505
    views
  • 589
    downloads
  • 75
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Alexandre B Roland
  2. Ana Ricobaraza
  3. Damien Carrel
  4. Benjamin M Jordan
  5. Felix Rico
  6. Anne C Simon
  7. Marie Humbert-Claude
  8. Jeremy Ferrier
  9. Maureen H McFadden
  10. Simon Scheuring
  11. Zsolt Lenkei
(2014)
Cannabinoid-induced actomyosin contractility shapes neuronal morphology and growth
eLife 3:e03159.
https://doi.org/10.7554/eLife.03159

Share this article

https://doi.org/10.7554/eLife.03159

Further reading

    1. Developmental Biology
    2. Genetics and Genomics
    Mehul Vora, Jonathan Dietz ... Cathy Savage-Dunn
    Research Article

    Smads and their transcription factor partners mediate the transcriptional responses of target cells to secreted ligands of the transforming growth factor-β (TGF-β) family, including those of the conserved bone morphogenetic protein (BMP) family, yet only a small number of direct target genes have been well characterized. In C. elegans, the BMP2/4 ortholog DBL-1 regulates multiple biological functions, including body size, via a canonical receptor-Smad signaling cascade. Here, we identify functional binding sites for SMA-3/Smad and its transcriptional partner SMA-9/Schnurri based on ChIP-seq peaks (identified by modEncode) and expression differences of nearby genes identified from RNA-seq analysis of corresponding mutants. We found that SMA-3 and SMA-9 have both overlapping and unique target genes. At a genome-wide scale, SMA-3/Smad acts as a transcriptional activator, whereas SMA-9/Schnurri direct targets include both activated and repressed genes. Mutations in sma-9 partially suppress the small body size phenotype of sma-3, suggesting some level of antagonism between these factors and challenging the prevailing model for Schnurri function. Functional analysis of target genes revealed a novel role in body size for genes involved in one-carbon metabolism and in the endoplasmic reticulum (ER) secretory pathway, including the disulfide reductase dpy-11. Our findings indicate that Smads and SMA-9/Schnurri have previously unappreciated complex genetic and genomic regulatory interactions that in turn regulate the secretion of extracellular components like collagen into the cuticle to mediate body size regulation.

    1. Developmental Biology
    Wei Yan
    Editorial

    The articles in this special issue highlight the diversity and complexity of research into reproductive health, including the need for a better understanding of the fundamental biology of reproduction and for new treatments for a range of reproductive disorders.